Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.
about
Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype
P2860
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@en
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@nl
type
label
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@en
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@nl
prefLabel
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@en
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@nl
P2093
P2860
P356
P1476
Population Pharmacokinetic Mod ...... tors to Efavirenz Disposition.
@en
P2093
Ingrid F Metzger
Jason D Robarge
Jessica Lu
Nancy Thong
Robert R Bies
Todd C Skaar
P2860
P356
10.1128/AAC.01813-16
P407
P577
2016-10-31T00:00:00Z